Adult T-Cell Leukemia/Lymphoma — Trials

Adult T-Cell Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

121 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Carlos Brites
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07555431	Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection(DOT-H)	recruiting	Phase 2	146	Carlos BritesOTHER	1	Jun 2, 2026	clinicaltrials
NCT07075328	A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma	recruiting	Phase 1 / Phase 2	49	Otsuka Medical Devices Co., Ltd. JapanINDUSTRY	1	Apr 29, 2026	clinicaltrials